Jump to content
RemedySpot.com

(No subject)

Rate this topic


Guest guest

Recommended Posts

Guest guest

search under neti pot-- and you will get quite a few sites. It is a

small pot-- looks like a lamp that houses a genie.. LOL.. you put the

spout up to one nostril and bend your head just right and the solution

comes out the other nostril (and the best part? It doesn't go down the

back of your throat) It washes all of the gunk out and helps clean out

bacteria, etc and change the pH of the sinuses to be deadly to bad

guys. For the solution there is a recipe--I have been doing it so long

that I don't measure any longer-- use pickling salt (more purified than

regular salt), distilled water and a pinch of baking soda

--

Peace Be With You!

~Pattie~ Mom to , 7; 4 3/4 (SDS,

hypogammaglobulinemia/CVID) and ph 3 1/2 (SDS)

" The friend who finds you when you might be lost is a very welcome

friend. " ~~Lessons from the Hundred-Acre Wood

Link to comment
Share on other sites

  • 1 month later...
Guest guest

Jo -

It's nice to hear good news. Isn't great when you find at least one person on

the outside who REALLY wants to help and seems to understand.

Maybe that's where the answer lies...it takes a village of the RIGHT people to

raise a child. Cheers to you!

Penny-------------------------------------------------------- " If a man does not keep pace with his companions, perhaps it is because he hears a different drummer.Let him step to the music he hears, however measured or far away. " --Henry Thoreau

Link to comment
Share on other sites

  • 4 years later...

In a message dated 2/1/2006 7:24:19 A.M. Central Standard Time, Vergel writes:

Study says pivotal hormone therapy trial was flawed

A 2002 study showing that hormone replacement therapy raises the risk of heart disease and breast cancer -- scaring many women away from the drugs -- was fundamentally flawed, according to new research.

"Women are now being told not to take hormones for heart disease prevention, and that may be totally wrong," said Dr. Klaiber, a Worcester, Massachusetts endocrinologist and lead author of the study to be published on Friday in the journal Fertility and Sterility.

Hormone replacement therapy was once routinely prescribed to women as they reached menopause in the belief that it would relieve unpleasant symptoms like hot flashes while protecting against heart disease and osteoporosis .

In July 2002, women taking estrogen and progestin were told to visit their doctors and perhaps stop taking the medication after the Women's Health Initiative (WHI) said a trial of Wyeth's Prempro showed that the drug raised the risk of heart attack , stroke and some forms of cancer.

But Prempro combines estrogen and progestin in a daily pill -- a regimen that had never been associated with heart protection, Klaiber said.

At the time of the WHI trial's design, hormone replacement therapy usually involved cyclical progesterone, meaning that it was taken just 10 or 12 days a month, he said.

But the daily combined drug was deemed more convenient because patients didn't have to remember which days to take a second pill and because it eliminated a monthly menstrual period, the researcher said.

"The results might have been different if they had used a different form of estrogen that resembled a normal cycle," Klaiber said.

The WHI study's other major flaw was that participants were older -- the mean age was 62.7 -- and thus at greater risk of cardiovascular problems.

"The incidence of heart disease is 12 times higher for women in their 80s than it is in the 50s," Klaiber said.

As a result, the WHI study began hormone therapy for the first time in women who already had heart disease, and "we know that's not a good idea," he added.

Klaiber believes that earlier studies showing that cyclical hormones are protective against heart disease are probably valid.

"One of the reasons we started giving estrogen to menopausal women was because of the gender differential -- men have a lot more heart attacks and have them earlier," he said.

He is hopeful that a multicenter trial launched last year by the Phoenix-based Kronos Longevity Research Institute will eventually show that hormone replacement therapy is not risky in women who are just beginning to go through menopause.

The Kronos study will treat women age 40 to 55 with hormone pills, hormones delivered through a skin patch, or placebo, but results won't be available until 2010.

"The studies conducted through the WHI make an important contribution to our knowledge, but they do not provide a complete answer," Dr. ph Sanfilippo, president of the American Society for Reproductive Medicine, said in a statement.

Regardless of its flaws, the WHI study was very useful because it showed that "Prempro was a mistake," Klaiber said. Read Full Story

Regards, Vergelpowerusa dot org"Our deepest fear is not that we are inadequate. Our deepest fear is that we are powerful beyond measure. It is our light, not our darkness, that most frightens us. We ask ourselves, Who am I to be brilliant, gorgeous, talented, fabulous? Actually, who are you not to be? Your playing small doesn't serve the world. There's nothing enlightened about shrinking so that other people won't feel insecure around you. We are all meant to shine, as children do... And as we let our own light shine, we unconsciously give other people permission to do the same. As we're liberated from our own fear, our presence automatically liberates others." — M. on, A Return to Love

Study says pivotal hormone therapy trial was flawed

A 2002 study showing that hormone replacement therapy raises the risk of heart disease and breast cancer -- scaring many women away from the drugs -- was fundamentally flawed, according to new research.

"Women are now being told not to take hormones for heart disease prevention, and that may be totally wrong," said Dr. Klaiber, a Worcester, Massachusetts endocrinologist and lead author of the study to be published on Friday in the journal Fertility and Sterility.

Hormone replacement therapy was once routinely prescribed to women as they reached menopause in the belief that it would relieve unpleasant symptoms like hot flashes while protecting against heart disease and osteoporosis .

In July 2002, women taking estrogen and progestin were told to visit their doctors and perhaps stop taking the medication after the Women's Health Initiative (WHI) said a trial of Wyeth's Prempro showed that the drug raised the risk of heart attack , stroke and some forms of cancer.

But Prempro combines estrogen and progestin in a daily pill -- a regimen that had never been associated with heart protection, Klaiber said.

At the time of the WHI trial's design, hormone replacement therapy usually involved cyclical progesterone, meaning that it was taken just 10 or 12 days a month, he said.

But the daily combined drug was deemed more convenient because patients didn't have to remember which days to take a second pill and because it eliminated a monthly menstrual period, the researcher said.

"The results might have been different if they had used a different form of estrogen that resembled a normal cycle," Klaiber said.

The WHI study's other major flaw was that participants were older -- the mean age was 62.7 -- and thus at greater risk of cardiovascular problems.

"The incidence of heart disease is 12 times higher for women in their 80s than it is in the 50s," Klaiber said.

As a result, the WHI study began hormone therapy for the first time in women who already had heart disease, and "we know that's not a good idea," he added.

Klaiber believes that earlier studies showing that cyclical hormones are protective against heart disease are probably valid.

"One of the reasons we started giving estrogen to menopausal women was because of the gender differential -- men have a lot more heart attacks and have them earlier," he said.

He is hopeful that a multicenter trial launched last year by the Phoenix-based Kronos Longevity Research Institute will eventually show that hormone replacement therapy is not risky in women who are just beginning to go through menopause.

The Kronos study will treat women age 40 to 55 with hormone pills, hormones delivered through a skin patch, or placebo, but results won't be available until 2010.

"The studies conducted through the WHI make an important contribution to our knowledge, but they do not provide a complete answer," Dr. ph Sanfilippo, president of the American Society for Reproductive Medicine, said in a statement.

Regardless of its flaws, the WHI study was very useful because it showed that "Prempro was a mistake," Klaiber said. Read Full Story

Link to comment
Share on other sites

  • 3 years later...

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...